That’s the question being asked by pharmacists throughout Ohio as a recent change in that state’s law allows the governor to appoint a pharmacy director with no experience in the field.
That’s the question being asked by pharmacists throughout Ohio as a recent change in that state’s law allows the governor to appoint a pharmacy director with no experience in the field.
Earlier this year, Gov. John Kasich appointed a new director of the state’s Board of Health who does not hold a medical degree. Then, according to the Dayton Daily News, he offered the job of directing the state pharmacy board to state Rep. Lynn Wachtmann, R-Napoleon, who turned it down.
Kasich was able to offer the job to Wachtmann because in June state legislators removed the requirement that the pharmacy board director be a licensed pharmacist. The last pharmacy director, Kyle Parker, stepped down this month.
“To us, as pharmacists, we strongly believe (the director) needs to be a pharmacist,” Ernie Boyd, spokesperson for the Ohio Pharmacy Association spokesman told the Dayton Daily News. “We feel that it’s a pretty important public position that requires a pretty specific knowledge base.”
Pharmacy board members who are appointed by the governor appoint the director of the board. A spokesman for Kasich said the governor supported the elimination of the requirement that the board director be a licensed pharmacist because the job does not pay enough ($128,900) to attract top pharmacists.
Pharmacists are not alone in objecting to the board being led by a non-pharmacist.
“The bottom line is that somebody who is not a pharmacist doesn’t understand the practice of pharmacy,” Robert Weber, the administrator for pharmacy services at Ohio State University’s Wexner Medical Center, told the newspaper. “It would not be a positive for the executive director to not be a pharmacist.”
Added State Rep. Connie Pillich, D-Montgomery, who voted against the change: “Taxpayers expect and deserve highly skilled professionals in positions of power. With the rise of prescription painkiller abuse in our state, I would think we need that expertise and leadership at the pharmacy board now more than ever before.”
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.